Calidi Biotherapeutics Secures Series A Investments to Advance Manufacturing

SourceBusiness Wire
Date Published01/21/2020

Additional Reshoring Information:

Company/Division name Calidi Biotherapeutics, Inc.
Parent companyCalidi Biotherapeutics, Inc.
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Year reshoring announced:2020
Country(ies) from which reshored:Korea, Republic of
City reshored to:San Diego
State(s) reshored to:CA
If relevant, work nearshored to:-
Product(s) reshoredcell-based immunotherapies for cancer
What domestic positive factors made reshoring more attractive?Automation/technology, Other, expansion
Find Reshoring Articles